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Background. Cognitive impairment and depression often co-occur in older adults, but it is not clear whether depression
is a risk factor for cognitive decline, a psychological reaction to cognitive decline, or whether changes in depressive
symptoms correlate with changes in cognitive performance over time. The co-morbid manifestation of depression and
cognitive impairment may reﬂect either a causal effect or a common cause, depending on the speciﬁc symptoms experi-
enced and the cognitive functions affected.
Method. The study sample comprised 1506 community-dwelling older adults aged 565 years from the Longitudinal
Aging Study Amsterdam (LASA). We conducted cross-domain latent growth curve analyses to examine longitudinal
associations between late-life depression dimensions (i.e. depressed affect, positive affect, and somatic symptoms) and
speciﬁc domains of cognitive functioning (i.e. processing speed, inductive reasoning, immediate recall, and delayed
recall).
Results. Poorer delayed recall performance at baseline predicted a steeper increase in depressed affect over time. Steeper
decline in processing speed correlated with a steeper increase in somatic symptoms of depression over time.
Conclusions. Our ﬁndings suggest a prospective association between memory function and depressed affect, whereby
older adults may experience an increase in depressed affect in reaction to poor memory function. Somatic symptoms of
depression increased concurrently with declining processing speed, which may reﬂect common neurodegenerative pro-
cesses. Our ﬁndings do not support the hypothesis that depression symptoms may be a risk factor for cognitive decline in
the general population. These ﬁndings have potential implications for the treatment of late-life depression and for the
prognosis of cognitive outcomes.
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Introduction
Extensive evidence suggests that late-life depression
co-occurs with cognitive dysfunctions affecting in par-
ticular ﬂuid cognitive abilities such as processing
speed, executive function, and episodic memory (e.g.
Comijs et al. 2001; Lockwood et al. 2002; Baudic et al.
2004; Sheline et al. 2006; Morimoto & Alexopoulos,
2013; Koenig et al. 2014). However, the direction of
inﬂuence remains unclear, leaving an unresolved ques-
tion of whether depression is a risk factor for cognitive
impairment, a psychological reaction to cognitive
impairment, or a prodromal syndrome of dementia.
To overcome problems of reversed causation, a num-
ber of studies have investigated bi-directional pro-
spective associations between depression symptoms
and cognitive functioning. Some studies found that
higher baseline levels of depressive symptoms pre-
dicted steeper decline in general cognitive performance
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in persons aged 60–80 years (Gale et al. 2012), steeper
decline in delayed recall and global cognitive function
in persons aged 65–84 years (Panza et al. 2009), as well
as slower processing speed and reaction time at follow-
up in persons aged 70–97 years (Bunce et al. 2014),
whereas baseline cognitive performance did not pre-
dict changes in depressive symptoms over time.
Other studies found evidence for the opposite direc-
tion of the effect whereby poorer attention and epi-
sodic memory in persons aged 585 years (Vinkers
et al. 2004), poorer episodic memory in persons aged
550 years (Jajodia & Borders, 2011), and poorer global
cognitive performance in persons aged 570 years
(Perrino et al. 2008) predicted an increase in depression
symptoms over time, whereas baseline depression
levels were unrelated to the rate of cognitive decline.
A study by van den Kommer et al. (2013) found evi-
dence for both directions of the effect whereby higher
depression symptoms at baseline predicted steeper
decline in processing speed and general cognitive abil-
ity over time, and slower processing speed at baseline
predicted an increase in depression symptoms over
time in persons aged 55–85 years. The same study by
van den Kommer et al. (2013) found no signiﬁcant
association between the course of depressive symp-
toms and the course of general cognitive functioning
or processing speed. The mixed evidence regarding
the longitudinal association between depression symp-
toms and cognitive functioning in late life may be due
to methodological differences between studies such as
the number of assessment waves included, the length
of follow-ups, the age range of participants, and the
cognitive and depression measures included.
Most of the longitudinal studies above measured
depression as a unidimensional construct and did
not distinguish between different symptom dimen-
sions. However, late-life depression is a heterogeneous
condition. Speciﬁc symptom presentations such as
depressed affect, low positive affect, somatic and
motivational, or cognitive symptoms may reﬂect dis-
tinct aetiologies, and may be differentially related to
the nature and course of cognitive impairment. For
instance, affective symptoms of depression may mani-
fest as a psychological reaction to mild or transitory
cognitive impairment, whereas an organic syndrome
of depression, consisting of psychomotor and cognitive
symptoms, may be more prevalent as cognitive func-
tioning deteriorates and older adults lose insight
about their cognitive deﬁcits (Ritchie et al. 1999).
Previous reports suggest that motivational and som-
atic symptoms of depression may be more strongly
related to cognitive impairment than affective symp-
toms. Cross-sectional ﬁndings suggest that ‘motiv-
ational disturbance’ was more strongly related to
verbal ﬂuency performance than ‘affective suffering’
symptoms (Castro-Costa et al. 2007; Brailean et al.
2015). Longitudinal ﬁndings suggest that patients
with a history of vascular disease who had poorer
baseline performance on executive function, process-
ing speed and memory tasks showed a higher increase
in a cluster of motivational and somatic symptoms of
depression compared to mood symptoms over 7
years of follow-up (Kooistra et al. 2015). These ﬁndings
are consistent with the depression-executive dysfunc-
tion hypothesis according to which motivational
symptoms of depression tend to occur in the context
of executive deﬁcits, possibly due to vascular disease
and a disruption of frontal-subcortical pathways
(Alexopoulos et al. 1997, 2002). Evidence for the prom-
inent role of motivational and somatic symptoms in
persons with cognitive impairment comes also from
studies suggesting that symptoms of fatigue, cognitive
complaints and sleep disturbance were associated with
‘cognitive impairment no dementia’ in the absence of
dysphoric and anhedonic symptoms (Potvin et al.
2010), and that motivational symptoms of depression
were dominant in the preclinical phase of Alzheimer
disease (Berger et al. 1999; Bartolini et al. 2005), and
in mild cognitive impairment (Kumar et al. 2006).
However, other ﬁndings suggest that depressed affect
and somatic symptoms were similarly related to cogni-
tive performance on attention and motor tasks in the
general population (Baune et al. 2007).
Evidence on the association between positive affect
and cognitive functioning is also inconclusive. Cross-
sectional studies suggest that positive affect was a
more robust predictor of cognitive performance across
a variety of tasks than depressed affect, somatic symp-
toms or interpersonal difﬁculties (La Rue et al. 1995),
that higher positive affect was related to better every
day problem solving (Paterson et al. 2016), and that
higher positive affect was related to better verbal
ﬂuency performance (before Bonferroni adjustment),
but not better memory, speed or attention (Baune
et al. 2007). Longitudinal ﬁndings by Turner et al.
(2015) suggest that lower baseline levels of positive
affect (but not somatic symptoms, interpersonal difﬁ-
culties, or depressed affect scores) were associated
with steeper decline in global cognition, episodic mem-
ory, and perceptual speed. Positive affect could help
maintain cognitive function by reducing stress hor-
mone levels and cardio-vascular risk, by improving
health behaviours such as diet, sleep, and physical
exercise, and by increasing the engagement in social
interactions and cognitively stimulating activities (for
a review see Pressman & Cohen, 2005).
Studies employing a longitudinal design and a
multidimensional approach to depression are needed
to clarify the direction of inﬂuence between depression
symptom dimensions and cognitive functioning, and
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to help gain a better understanding of the neurobio-
logical and psychological mechanisms underlying the
co-morbid manifestation of depression and cognitive
impairment in late-life. Our study aims to examine lon-
gitudinal associations between speciﬁc depression
symptom dimensions (i.e. depressed affect, positive
affect, somatic symptoms) and speciﬁc domains of cog-
nitive functioning (i.e. processing speed, inductive rea-
soning, immediate recall, delayed recall) in older
adults. If depression symptoms develop as a psycho-
logical reaction to cognitive impairment, we would
expect lower baseline cognitive functioning to predict
an increase in depression symptoms over time. This
effect may be stronger for affective symptoms of
depression. If depression symptoms are a risk factor
for cognitive impairment, we would expect higher ini-
tial depression levels to predict steeper cognitive
decline. This effect may be stronger for somatic symp-
toms of depression. If cognitive impairment and
depression symptoms share a similar aetiology (e.g.
dementia-related neuropathology, cerebrovascular dis-
eases) we would expect a synchronous relationship
whereby an increase in depression symptoms would
correlate with declining cognitive function over time.
This effect is more likely to be observed for somatic
symptoms of depression. The simultaneous examin-
ation of these hypotheses could help clarify the effect
magnitude and direction of inﬂuence between cogni-
tive abilities and late-life depression dimensions. For
comparison purposes we include also an examination
of the longitudinal associations between cognitive abil-
ities and depression conceptualized as a unitary con-
struct (i.e. total CES-D score).
Method
Participants
Data were used from the Longitudinal Aging Study
Amsterdam (LASA; Huisman et al. 2011), an ongoing
study exploring physical, emotional, cognitive and
social functioning in late life in a nationally representa-
tive sample. Respondents were recruited from the
population registers of 11 municipalities from three
regions in The Netherlands, and were interviewed in
their homes by trained persons. In the current study
the baseline measurement consisted of data collected
in 1995–1996 from participants aged 65–89 years
(N = 1506) with the aim of ensuring that the proportion
of data present at baseline was over 90% on both de-
pression and cognitive measures. Four follow-up mea-
surements were included in this study: 1998–1999
(wave 2), 2001–2002 (wave 3), 2005–2006 (wave 4),
and 2008–2009 (wave 5). Fig. 1 presents the number
of respondents included in each measurement wave,
the attrition rates and the reasons for dropout.
Instruments
Depressive symptoms were assessed using the Centre for
Epidemiologic Studies Depression Scale (CES-D;
Radloff, 1977). Participants were asked to report how
often they experienced certain symptoms of depression
in the past week, and their responses were rated using a
four-point Likert scale, where 0 = ‘rarely or never’;
1 = ‘some of the time’; 2 = ‘occasionally’; 3 = ‘mostly or
always’. CES-D has good psychiatric properties in
older adults (Himmelfarb & Murrell, 1983; Hertzog
et al. 1990; McCallum et al. 1995). A cut-off score of 16
can be used to identify persons with major depression
(Beekman et al. 1997). CES-D was originally posited as
having a four-factor structure: depressed affect, positive
affect, somatic symptoms and interpersonal difﬁculties
(Radloff, 1977). This factor structure was conﬁrmed in
the LASA sample (Beekman et al. 1997; Brailean et al.
2016). However, the interpersonal difﬁculties factor
may be poorly measured (i.e. it consists of only two
items) and it is not in line with the current diagnosis cri-
teria for depression (for a review see Carleton et al.
2013). Therefore, in our analyses we only included the
subscale scores for positive affect (items: 4, 8, 12, 16),
depressed affect (items: 3, 6, 9, 10, 14, 17, 18), and som-
atic symptoms (items: 1, 2, 5, 7, 11, 13, 20).
Episodic memory was assessed using the 15 Words
Test, a Dutch version of the Auditory Verbal
Learning Test (Rey, 1964). Fifteen words were verbally
presented to participants and repeated over three
trials. Participants were required to repeat the words
they remembered at the end of each trial. The total
score on the three trials was used as a measure of
immediate recall. After a distraction period of about
20 min participants were asked to name again the
words they remembered. This was used as a measure
of delayed recall.
Information processing speed was assessed in LASA
using an adaptation of the Coding Task (Savage,
1984). Participants were shown two rows, the upper
one containing characters and the lower one being
empty. Participants were asked to name the character
in the bottom row which belonged to the character in
the upper row and they were instructed to respond
to the letter combinations as quickly and accurately
as possible. The correct letter combination was pre-
sented at the top of the page. The task consisted of
three trials and each trial lasted for 1 min. Scores
were calculated based on the number of completed
combinations. In our analyses we used the total score
for the three trials. Because participants were asked
to make a verbal response, it is considered that this
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adapted version of the task measures cognitive speed
rather than motor speed.
Inductive reasoning was assessed using the Raven
Coloured Progressive Matrices (RCPM; Raven, 1995).
Participants were shown a drawing from which a sec-
tion was missing and they were asked to identify the
correct missing section from six alternatives patterns
presented at the bottom of the page. Raven consists ori-
ginally of three subsets: A, Ab and B, but only subsets
A and B were used in LASA. Each subset consists of 12
items, and both items and subsets show a progressive
increase in difﬁculty. The number of correct responses
to each item was used to calculate the total score. The
sum score of A and B subsets ranged from 0 to 24.
General cognitive performance was assessed with the
Mini Mental State Examination (MMSE; Folstein et al.
1975), a widely used instrument in epidemiological
studies to screen for cognitive impairment and to
assess general cognitive functioning in older adults.
The MMSE shows satisfactory reliability and construct
validity (Tombaugh & McIntyre, 1992). Scores range
from 0 to 30 with higher scores indicating better cogni-
tive performance.
Statistical analysis
First, univariate latent growth curve models (LGCMs),
as a function of time in study, were ﬁtted independ-
ently to each outcome measure: depressed affect, posi-
tive affect, somatic symptoms, immediate recall,
delayed recall, processing speed and inductive reason-
ing. Univariate LGCMs allow for an examination of (1)
the initial level of a target outcome (i.e. intercept); (2)
its rate of change (i.e. slope) and the form of this
change (i.e. linear or nonlinear latent growth trajec-
tory); (3) the association between the initial level of
the outcome and its rate of change (e.g. persons who
start off with poorer cognitive performance show stee-
per cognitive decline over time). Various predictors can
also be added to these models to show their associa-
tions with the initial levels (i.e. intercept) and rate of
change (i.e. slope) in the target outcome. In our models
the intercept of each target outcome was centred at
baseline and a linear form of the latent growth trajec-
tory was tested. Intercepts and slopes of all target out-
comes were adjusted for baseline age (in years), gender
and education (in years). Age and education were
centred at their mean values in order to help with
model estimation and with the interpretation of the
estimates.
After establishing the linearity of the latent growth
trajectories and ensuring good model ﬁt in univariate
LGCMs, we conducted cross-domain LGCMs to exam-
ine the association between each cognitive ability
(inductive reasoning, processing speed, immediate
recall or delayed recall) and each depression dimen-
sion (depressed affect, positive affect and somatic
symptoms). On top of the parameters estimated in uni-
variate LGCMs, cross-domain LGCMs estimated asso-
ciations between: (1) baseline cognitive performance
and baseline depression symptoms; (2) baseline cogni-
tive performance and the rate of change in depression
symptoms; (3) baseline depression symptoms and the
rate of change in cognitive performance; (4) the rate
of change in depression symptoms and the rate of
change in cognitive performance (Fig. 2). These models
were adjusted for baseline age (in years), gender and
education (in years).
Sensitivity LGCM analyses were conducted to inves-
tigate the association between depression and cogni-
tive functioning in the context of adjustment for
potential confounders. Based on previous research
(Blazer, 2003; Alexopoulos, 2005; Alzheimer’s Disease
International, 2014; Baumgart et al. 2015; Vassilaki
et al. 2015), the following confounders were considered
as potentially relevant: chronic diseases (i.e. non-
speciﬁc lung disease, cardiac disease, peripheral arter-
ial disease, diabetes mellitus, cerebrovascular accident
or stroke, osteoarthritis or rheumatoid arthritis, cancer,
hypertension and a maximum of two other diseases of
which symptoms and treatment persisted for at least
3 months), alcohol use (no, middle, and high
Fig. 1. Flow chart of the study sample.
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consumption according to the Netherlands Economic
Institute index), exercise (total time spent on physical
activities in minutes per day), social network (number
of persons with whom the participant is has regular
contact), use of antidepressant and anxiolytic medica-
tion (user v. non-user, based on an inspection of medi-
cine bottles during the medical interview), smoking
(current, past, or never smoker). We also repeated the
cross-domain LGCM analyses using the total CES-D
score instead of domain-speciﬁc scores. This additional
set of sensitivity analyses included partially adjusted
models (i.e. controlling for age, gender and education)
and fully adjusted models (i.e. controlling for all the
additional confounders mentioned above).
All analyses were conducted in MPlus v. 7.2 (Muthén
and Muthén, 1998–2012). Maximum Likelihood Robust
(MLR) estimation was used for all models. MLR is
robust to non-normality and calculates parameters
using both cases with complete data and cases with
partially missing data. MLR estimation deals with
missing data under the missing at random (MAR)
assumption whereby attrition can be related to the
observed values of both covariates and outcomes.
When the missing data mechanism is MAR, missing
data is assumed to be ‘non-informative’ or ‘ignorable’
(Little & Rubin, 1987) and model parameters estimated
in the presence of missing data would be similar to the
situation in which data had been complete. Model ﬁt
was evaluated based on the model χ² with a p value
>0.05 indicating good model ﬁt (Hu & Bentler, 1999);
the comparative ﬁt index (CFI) (Bentler, 1990) and
the Tucker–Lewis index (TLI; Tucker & Lewis, 1973)
with values >0.90 suggesting acceptable ﬁt, and values
>0.95 indicating good ﬁt; the root mean square error of
approximation (RMSEA) (Steiger, 1990) with values
<0.06 indicating good ﬁt.
Ethical standards
The authors assert that all procedures contributing to
this work comply with the ethical standards of the rele-
vant national and institutional committees on human
experimentation and with the Helsinki Declaration of
1975, as revised in 2008.
Results
Descriptive statistics for our sample are presented in
Table 1. Among respondents 51.7% were females,
and 13.8% of participants had a MMSE score of 423,
indicative of cognitive impairment (Tombaugh &
McIntyre, 1992). A CES-D score of 516, indicative of
clinically relevant depressive symptoms, was found
in 15.8% (N = 228) of participants (Berkman et al.
1986; Beekman et al. 1997). Clinical interviews using
the Diagnostic Interview Schedule (Robins et al. 1981)
were carried out among participants with a CES-D
score of516. Among those interviewed, 37 had a diag-
nosis of depression in the past 6 months; 21 of them
experienced their ﬁrst episode of depression before
age 60 years, and 16 of them experienced their ﬁrst
episode of depression after age 60 years. The age of
depression onset was based on participants’ self-
reports. The use of antidepressants and anxiolytics
was related to cognitive performance on some, but
not all cognitive tests (see Supplementary Table S2).
Attrition rates and the reason for dropout are pre-
sented in Fig. 1. The high attrition rates observed in
our study are a typical ﬁnding in longitudinal ageing
Fig. 2. Cross-domain latent growth curve model (LGCM).
Cross-domain LGCM illustrating the association between
depression and cognitive functioning. Single-headed arrows
represent regression effects. Double-headed arrows represent
correlations. The intercepts of both depression and cognition
are centred at baseline. The slopes of cognition and
depression represent changes in these outcomes over ﬁve
assessment occasions during 13 years of follow-up. The
intercepts and slopes of all depression dimensions and
cognitive abilities were regressed on relevant covariates. For
the sake of clarity, the effect of covariates on the intercept
and slope of depression and cognition are not presented in
this ﬁgure.
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studies. Mortality accounted for over 80% of dropout
rates. Other reasons included refusal, ineligibility and
lack of contact. Higher dropout rates over the 13
years of follow-up were associated with being older
[odds ratio (OR) 1.19, 95% conﬁdence interval (CI)
1.16–1.21], being male (OR 0.56, 95% CI 0.45–0.70),
having lower baseline levels of immediate recall (OR
0.88, 95% CI 0.86–0.90), delayed recall (OR 0.78, 95%
CI 0.75–0.81), processing speed (OR 0.97, 95% CI
0.97–0.98), and inductive reasoning (OR 0.85, 95% CI
0.83–0.88), as well as having higher baseline levels of
depressed affect (OR 1.07, 95% CI 1.03–1.11) and som-
atic symptoms (OR 1.05, 95% CI 1.01–1.09), and lower
levels of positive affect (OR 0.95, 95% CI 0.91–0.98).
Univariate latent growth models
Table 2 presents results from univariate models
adjusted for age, gender and education. Model ﬁt for
all univariate models was good and it ranged from
CFI = 0.94, TLI = 0.92, RMSEA = 0.07 (90% CI 0.06–
0.08) for immediate recall to CFI = 1.00, TLI = 1.00,
RMSEA < 0.01 (90% CI 0.00–0.02) for inductive reason-
ing. The mean of the intercept and slope was statistic-
ally signiﬁcant for all outcome measures, indicating a
signiﬁcant linear change in scores over time. Sample
and estimated means for each depression and
cognitive outcome measure are presented in
Supplementary Table S4. Supplementary Figs S1–S7
present the observed individual scores for each cogni-
tive domain and each depression dimension across
time points. Participants showed an increase in
depressed affect and somatic symptoms, as well as a
drop in positive affect over time. A decline in perform-
ance was observed for all cognitive abilities. The inter-
cept and slope of our outcome measures should be
interpreted as the initial level and rate of change in
the outcome for a person of average age (75.9 years)
and average level of education (8.9 years). The variance
of the slope for positive affect was not statistically sig-
niﬁcant, whereas the variance of the intercept and
slope for all other outcome measures was statistically
signiﬁcant, indicating that both the initial level and
rate of change in depression and cognitive scores var-
ied between individuals. The only signiﬁcant correl-
ation between intercept and slope was found for
processing speed, indicating that participants with
higher baseline performance had steeper decline in
processing speed over time, which could reﬂect an
effect of regression to the mean. The rate of decline
in other cognitive measures was not dependent on
the initial level of cognitive performance.
Cross-domain latent growth models
Table 3 shows results of the cross-domain models. All
cross domain models ﬁtted the data well: CFI5 0.95;
TLI5 0.94; RMSEA4 0.04 (90% CI 0.04–0.05). Fit
Table 1. Descriptive statistics
Continuous measures N Mean S.D. Categorical measures Category N %
Age (years) 1506 75.9 6.6 Gender Male 725 48
Education (years) 1504 8.9 3.3 Female 778 52
Depressed affect 1451 1.8 2.9 Chronic diseases 0 237 16
Positive affect 1408 8.6 3.1 1 454 30
Somatic symptoms 1443 2.9 3.1 2 429 29
Processing speed 1403 68.1 22.0 3 232 15
Inductive reasoning 1425 17.2 4.1 4 112 7
Immediate recall 1457 18.8 6.4 55 38 3
Delayed recall 1457 5.5 3.0 Antidepressants User 41 3
MMSE 1502 26.5 3.3 Not user 1462 97
Physical activity 1438 40 57 Anxiolytics User 103 7
Social network size 1447 14.0 8.2 Not user 1400 93
Smoking Never 539 36
Past 680 45
Current 288 19
Alcohol Never 388 26
Moderate 975 65
Severe 140 9
MMSE, Mini Mental State Examination.
Physical activity was measured as the total time spent being physically active in minutes per day; social network was
measured as the number of persons with whom the participant has regular contact.
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indices for each model are presented in Supplementary
Table S3. Lower baseline levels of processing speed
and immediate recall were signiﬁcantly associated
with higher baseline levels of depressed affect and
somatic symptoms, as well as lower levels of positive
affect. Higher baseline levels of inductive reasoning
were signiﬁcantly associated with lower depressed
affect and lower somatic symptoms. No association
was found between baseline levels of delayed recall
and baseline levels of depressed affect, positive affect
or somatic symptoms. Baseline delayed recall perform-
ance predicted a statistically signiﬁcant steeper in-
crease in depressed affect over time. Initial levels of
performance in other cognitive domains were unre-
lated to rates of change in depressed affect, positive
affect or somatic symptoms. Also, initial levels of
depressed affect, positive affect or somatic symptoms
were unrelated to changes over time in any cognitive
domains. In terms of the association between changes
in depressive symptoms and changes in cognitive
functioning over time, we only found that decline in
processing speed performance was related to an
increase in somatic symptoms over time.
Sensitivity analyses revealed that adjustment for
additional confounders (i.e. number of chronic dis-
eases, physical activity, social network size, alcohol
use, use of antidepressant and anxiolytic medication,
and smoking) did not change substantive conclusions
about the longitudinal associations between depres-
sion symptom-dimensions and cognitive abilities (see
Supplementary Table S1). The association between
processing speed decline and the increase in somatic
symptoms remained statistically signiﬁcant in the
fully adjusted models, whereas the effect of baseline
delayed recall scores on changes in depressed affect
was marginally signiﬁcant (p = 0.05). An additional
set of sensitivity analyses using the total CES-D scores
revealed that overall depression levels at baseline did
not predict the rate of decline in any cognitive ability
(see Supplementary Table S5). Higher initial levels of
delayed recall predicted an increase in overall depres-
sion levels over time, and the effect remained statistic-
ally signiﬁcant in the fully adjusted model. An increase
in overall depression levels was associated with
decline in immediate recall, processing speed and
inductive reasoning in the partially adjusted models,
but only the association between processing speed
and depression symptoms remained statistically sig-
niﬁcant in the fully adjusted models.
Conclusions
Using data from a large nationally representative
sample of LASA and a multidimensional approach to
late-life depression, this longitudinal study examined
associations between depression dimensions and cog-
nitive functioning in late-life. Our ﬁndings suggest
signiﬁcant cross-sectional associations between base-
line depression dimensions and cognitive performance
on processing speed, inductive reasoning and imme-
diate recall tasks. These ﬁndings are consistent with
evidence that late-life depression co-occurs with
impairment in ﬂuid cognitive abilities (e.g. Comijs
et al. 2001; Butters et al. 2004; Sheline et al. 2006;
Baune et al. 2007; Koenig et al. 2014). Our longitudinal
ﬁndings suggest that older adults showed signiﬁcant
decline over time in all cognitive abilities, which is in
line with a large body of knowledge suggesting that
cognitive decline is part of normal ageing (e.g.
Brayne et al. 1999; Wilson et al. 1999; Park et al. 2003).
Furthermore, older adults showed an increase in
depressed affect and somatic symptoms, as well as a
Table 2. Estimates for univariate latent growth curve models (LGCMs)
Measure Mean intercept Mean slope Variance intercept Variance slope
Correlation
between intercept
and slope
r S.E.
Inductive reasoning 17.06 −0.17 7.22 0.02 0.06 0.13
Processing speed 65.60 −1.47 278.4 0.67 −0.22*** 0.06
Immediate recall 17.17 −0.42 18.75 0.05 −0.07 0.13
Delayed recall 4.68 −0.18 4.58 0.02 −0.15 0.09
Depressed affect 1.22 0.09 3.96 0.01 −0.08 0.19
Positive affect 9.07 −0.13 4.00 <0.01 −0.01 0.26
Somatic symptoms 2.38 0.15 5.10 0.02 −0.12 0.15
***p < 0.001; the value of the slope reﬂects the yearly change in the outcome measure; means and variances of all intercepts
and slopes are statistically signiﬁcant, except for the variance of the slope for positive affect; results presented are based on
univariate LGCMs for each outcome measure, after adjustment for age, gender and education.
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drop in positive affect over time, which is consistent
with previous ﬁndings suggesting an increase in
depressive symptoms in old age (Meeks et al. 2011;
Sutin et al. 2013).
Regarding the effect of baseline cognitive perform-
ance on the course of depression symptom-dimensions,
our ﬁndings indicate that poor delayed recall perform-
ance at baseline predicted an increase in depressed
affect over time, but it did not predict changes in posi-
tive affect or somatic symptoms of depression. Poorer
delayed recall performance at baseline predicted also
an increase in overall depression symptoms (i.e. total
CES-D score), which is consistent with previous reports
(Vinkers et al. 2004; Jajodia & Borders, 2011). The
increase in depressed affect in persons with poor base-
line delayed recall may indicate a psychological reac-
tion to perceived memory dysfunction. Older adults
may be more likely to notice their memory problems
than other cognitive dysfunction (such as slow process-
ing speed). Memory failure may cause difﬁculties in
daily living and related-challenges, which could lead
to increasing depressed affect. As our study did not
assess subjective memory complaints, the level of
insight that participants had about their memory loss
remains unknown. However, the effect of initial
delayed recall performance on the slope of depressed
affect remained statistically signiﬁcant after adjusting
for relevant confounders. An alternative explanation
for our ﬁnding is that the same neurodegenerative
mechanisms may underlie both delayed recall dysfunc-
tion and the increase in depression symptoms.
According to previous reports, delayed recall measures
predict conversion from mild cognitive impairment to
Alzheimer’s disease better than measures of other cog-
nitive abilities (Gainotti et al. 2014), and the risk of con-
version is higher among older adults with amnestic
cognitive impairment who also present clinical depres-
sion, compared to those without depression (Modrego
& Ferrandez, 2004). If delayed recall dysfunction and
depression symptoms were manifestations of demen-
tia-related neurodegenerative processes, we would
have expected delayed recall decline to correlate with
an increasing trajectory of depression symptoms. This
effect was not found in our study.
Regarding the effect of baseline depression symp-
tom-dimensions on cognitive decline, our ﬁndings
Table 3. Estimates for cross-domain latent growth curve models
Depression dimension
Depressed affect Positive affect Somatic symptoms
Cognitive ability β S.E. β S.E. β S.E.
Processing speed
I Cog↔ I Dep −0.16*** 0.03 0.13** 0.04 −0.20*** 0.04
I Dep→ S Cog 0.08 0.08 −0.13 0.08 0.14 0.07
I Cog→ S Dep −0.18 0.10 0.28 0.21 −0.04 0.10
S Cog↔ S Dep −0.18 0.12 0.82 0.53 −0.38* 0.16
Inductive reasoning
I Cog↔ I Dep −0.14** 0.05 0.07 0.05 −0.18*** 0.05
I Dep→ S Cog −0.04 0.11 0.08 0.11 0.01 0.11
I Cog→ S Dep −0.12 0.12 0.29 0.26 0.12 0.12
S Cog↔ S Dep −0.26 0.17 0.64 0.51 −0.32 0.18
Immediate recall
I Cog↔ I Dep −0.11** 0.04 0.10* 0.05 −0.12** 0.04
I Dep→ S Cog 0.16 0.11 −0.06 0.11 0.11 0.10
I Cog→ S Dep −0.18 0.12 0.10 0.21 −0.19 0.12
S Cog↔ S Dep −0.32 0.17 0.56 0.43 −0.25 0.17
Delayed recall
I Cog↔ I Dep −0.07 0.04 0.04 0.04 −0.08 0.04
I Dep→ S Cog −0.02 0.10 0.04 0.10 0.01 0.10
I Cog→ S Dep −0.25* 0.11 0.45 0.28 −0.18 0.11
S Cog↔ S Dep 0.06 0.14 −0.21 0.35 −0.03 0.14
β, Standardized estimates; I Cog, intercept of cognitive ability; I Dep, intercept of depression dimension; S Cog, slope of
cognitive ability; S Dep, slope of depression dimension; double-headed arrows represent correlations, whereas single-headed
arrows represent regression effects; all models are adjusted for age, gender and education.
*p < 0.05, **p < 0.01, ***p < 0.001, statistically signiﬁcant results are presented in bold.
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suggest that baseline levels of depressed affect, positive
affect, and somatic symptoms did not predict the rate
of cognitive decline. This was also the case for overall
depression symptoms (total CES-D score). These
ﬁndings argue against the hypothesis that depression
may be a risk factor for cognitive decline. Our ﬁndings
conﬂict with previous reports indicating that higher
baseline depression scores predicted accelerated
decline in episodic memory (Panza et al. 2009;
Zahodne et al. 2014), processing speed (van den
Kommer et al. 2013), and general cognitive perform-
ance (Gale et al. 2012; van den Kommer et al. 2013),
and are inconsistent with meta-analytic evidence that
depressed persons have an increased risk of incident
dementia (Ownby et al. 2006; Diniz et al. 2013;
Alzheimer’s Disease International, 2014; Cherbuin
et al. 2015). It is possible that a prospective effect of
depression on cognitive decline may have been
observed with a shorter follow-up duration than the
one used in our study. According to previous reports
(Alzheimer’s Disease International, 2014; Mirza et al.
2014), the prospective effect of depression symptoms
on dementia was stronger in studies with shorter fol-
low-up durations, which is consistent with the hypoth-
esis that depression may be a prodromal manifestation
of dementia rather than an independent risk factor.
Furthermore, it is possible that a clinical diagnosis of
depression, rather than subclinical depression symp-
toms, may ﬂag an increased risk for cognitive decline.
In our study only a small percentage of participants
had clinically signiﬁcant depression symptoms (i.e. a
CES-D score of 516) or a clinical diagnosis of
depression.
Regarding the associations between changes in
speciﬁc symptom-dimensions of depression and
changes in cognitive functioning, our ﬁndings suggest
that increasing severity of somatic symptoms of
depression over 13 years of follow-up showed a
speciﬁc association with steeper decline in processing
speed. This effect remained statistically signiﬁcant
after adjusting for potential confounders. After adjust-
ment for confounders, an increase in overall depression
symptoms (i.e. total CES-D score) was only associated
with declining processing speed over time. This is
inconsistent with previous reports suggesting that
changes in processing speed were unrelated to changes
in overall depression symptoms in participants aged
555 years (van den Kommer et al. 2013). The discrep-
ancy between these ﬁndings may be partly explained
by the inclusion of older participants in our study
(aged 565 years). The concurrent manifestation of
somatic symptoms of depression and slow processing
speed may be more relevant at advanced ages, but
the underlying aetiological mechanisms are yet to be
clariﬁed. Previously, Kooistra et al. (2015) reported
that slower processing speed at baseline was asso-
ciated with a larger increase in a cluster of somatic
and motivational symptoms of depression (compared
to mood symptoms) over 7 years of follow-up. The
somatic and motivational symptoms of depression
assessed by Kooistra et al. (2015) were similar to the
symptoms assessed in our study with the somatic sub-
scale of CES-D (i.e. appetite disturbance, energy loss,
sleep disturbance, concentration problems, psycho-
motor retardation). Taken together, these ﬁndings sug-
gest that somatic and motivational symptoms of
depression and processing speed impairment may be
clinical manifestation of the same neurodegenerative
processes, such as white matter lesions or vascular dis-
ease (Alexopoulos et al. 1997, 2002; Naarding et al.
2005). The speciﬁc association between changes in
somatic symptoms and changes in processing speed
in our study may also reﬂect the fact that the somatic
subscale of CES-D and the processing speed task
used in our study measure similar constructs. For
instance, some of the items that are part of the somatic
subscale of CES-D assess cognitive complaints (i.e. con-
centration difﬁculties, feeling that everything is an
effort, not being able to get going).
Our ﬁndings suggest that an accelerated rate of cog-
nitive decline may be associated with an increase in
depression symptoms over time rather than with
higher initial depression scores. In particular, the pres-
ence of somatic symptoms of depression may indicate
a chronic course of cognitive decline which is primarily
reﬂected in slow processing speed. These ﬁndings are
consistent with evidence that the risk of dementia is
particularly high in older adults who experience a
chronic course of depression (i.e. an increasing trajec-
tory of depression), but not in those who experience
transient depression (i.e. high scores at a particular
time point, followed by remission) (Kaup et al. 2016;
Mirza et al. 2016).
Strengths of this study include the large sample size,
the long follow-up period, the dimensional approach
to late-life depression, and the assessment of several
cognitive abilities which are commonly impaired in
late-life depression. A ﬁrst notable limitation of our
study is the high attrition rate over the course of the
follow-up, largely due to mortality. Participants with
more severe depression symptoms and poorer cogni-
tive functioning at baseline were more likely to drop
out from the study over the course of the follow-up.
The selective loss of more cognitively impaired and
more severely depressed individuals over the course
of the follow-up may have resulted in an underestima-
tion of the effects found in this study. We dealt with
missing data using the maximum likelihood estimation
under the missing at random assumption. However,
this assumption cannot be veriﬁed, and there remains
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a possibility that ﬁndings may differ if data were miss-
ing not at random. Second, our ﬁndings are only rele-
vant to community dwelling older adults and cannot
be generalized to clinical populations. Third, it is pos-
sible that our ﬁndings may relate to the speciﬁc tasks
used rather than the cognitive domains being studied.
However, we cannot examine this given that only one
test was available for each cognitive measure in LASA.
Fourth, our models are not adjusted for multiple test-
ing. Although Type 1 error (i.e. the probability of
detecting an effect that is not present) could have
been reduced by adjusting for multiple testing, this
would have been at the expense of the Type 2 error
(i.e. failing to detect an effect that is present), and
would have reduced the power to detect potentially
important effects (Gelman et al. 2012). Due to the
large number of tests conducted and the correlations
among model parameters, traditional methods of cor-
recting for Type 1 error may be overly conservative
in the context of our LGCM analyses. Of note, the sim-
ultaneous estimation of the effect of baseline depres-
sion on cognitive decline and the effect of baseline
cognitive performance on the course of depressive
symptoms allows to determine relative predictive asso-
ciations, without implying a true causal effect and
without clarifying the aetiological factors that may
underlie the observed associations.
In conclusion, our ﬁndings do not support the
hypothesis that speciﬁc depression symptom clusters
may predict an increased rate of cognitive decline.
However, our ﬁndings support a prospective effect of
memory function on the course of depressed affect,
which may indicate a psychological reaction to poor
memory function. This implies that maintaining good
cognitive functioning by engaging in memory enhanc-
ing activities could help older adults cope with ageing
related challenges and protect them against depres-
sion. Furthermore, our ﬁndings support a synchronous
longitudinal association between the course of process-
ing speed performance and the course of somatic
symptoms of depression. More research is needed to
understand whether somatic symptoms of depression
are an early sign of cognitive impairment or a pro-
dromal syndrome of dementia, and whether the early
diagnosis and treatment of depression among older
adults presenting somatic complaints may improve
cognitive outcomes. Future studies could also examine
whether older adults with speciﬁc trajectory classes
(e.g. chronic, remitting, relapsing depression) of
depression symptom-dimensions (e.g. depressed
affect, positive affect, somatic symptoms) present an
accelerated rate of cognitive decline and an increased
risk of dementia. A better understanding of the nature,
direction and timing of the association between
depression symptom dimensions and cognitive
functioning in late-life, and of the underlying aetio-
logical mechanisms, could help develop targeted inter-
ventions aimed at improving cognitive outcomes
among older adults with speciﬁc depression symptom
proﬁles.
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